Division of Cancer Medicine, MD Anderson Cancer Center, Houston, Texas.
Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts.
JAMA Oncol. 2015 Apr;1(1):50-8. doi: 10.1001/jamaoncol.2014.112.
Shared decision making is associated with improved patient-reported outcomes of cancer treatment, but not all patients prefer to participate in medical decisions. Results from studies of the effect of matching between actual and preferred medical decision roles on patients' perceptions of care quality have been conflicting.
To determine whether shared decision making was associated with patient ratings of care quality and physician communication and whether patients' preferred decision roles modified those associations.
DESIGN, SETTING, AND PARTICIPANTS: We performed a population- and health system-based survey of participants in the Cancer Care Outcomes Research and Surveillance Consortium (CanCORS) study diagnosed with lung and/or colorectal cancer between 2003 and 2005 (56% with colorectal cancer, 40% with non-small-cell lung cancer, and 5% with small-cell lung cancer). The CanCORS study included 9737 patients (cooperation rate among patients contacted, 59.9%) treated in integrated care delivery systems, academic institutions, private offices, and Veterans Affairs hospitals. The medical records were abstracted between October 11, 2005, and April 30, 2009; all analyses were conducted between 2013 and 2014.
We surveyed patients specifically about their preferred roles in cancer treatment decisions and their actual roles in decisions about surgery, chemotherapy, and radiation therapy. We analyzed the responses of 5315 patients who completed baseline surveys and reported decision roles for a total of 10 817 treatment decisions and assessed associations of patients' decision roles with patient-reported quality of care and physician communication.
The outcomes (identified before data collection) included patient-reported excellent quality of care and top ratings (highest score) on a physician communication scale.
After adjustment, patients describing physician-controlled (vs shared) decisions were less likely to report excellent quality of care (odds ratio [OR], 0.64; 95% CI, 0.54-0.75; P < .001). Patients' preferred decision roles did not modify this effect (P = .29 for the interaction). Patients describing either actual or preferred physician-controlled (vs shared) roles were less likely to provide a top rating of physician communication (OR, 0.55; 95% CI, 0.45-0.66; P < .001, and OR, 0.67; 95% CI, 0.51-0.87; P = .002, respectively). The preferred role did not modify the effect of the actual role (P = .76 for interaction).
Physician-controlled decisions regarding lung or colorectal cancer treatment were associated with lower ratings of care quality and physician communication. These effects were independent of patients' preferred decision roles, underscoring the importance of seeking to involve all patients in decision making about their treatment.
共同决策与改善癌症治疗的患者报告结局相关,但并非所有患者都愿意参与医疗决策。关于实际和偏好的医疗决策角色匹配对患者护理质量感知的影响的研究结果存在冲突。
确定共同决策是否与患者对护理质量和医生沟通的评价相关,以及患者偏好的决策角色是否改变了这些关联。
设计、设置和参与者:我们对癌症护理结果研究和监测联盟(CanCORS)研究中的参与者进行了一项基于人群和卫生系统的调查,这些参与者在 2003 年至 2005 年间被诊断患有肺癌和/或结直肠癌(56%为结直肠癌,40%为非小细胞肺癌,5%为小细胞肺癌)。CanCORS 研究包括 9737 名患者(联系患者的合作率为 59.9%),他们在综合护理提供系统、学术机构、私人诊所和退伍军人事务医院接受治疗。病历于 2005 年 10 月 11 日至 2009 年 4 月 30 日提取;所有分析均于 2013 年至 2014 年进行。
我们特别调查了患者在癌症治疗决策中的偏好角色以及他们在手术、化疗和放疗决策中的实际角色。我们分析了完成基线调查并报告了总共 10817 项治疗决策的决策角色的 5315 名患者的反应,并评估了患者的决策角色与患者报告的护理质量和医生沟通之间的关联。
结果(在数据收集之前确定)包括患者报告的护理质量极好和医生沟通量表的最高分(最高评分)。
调整后,描述医生控制(vs 共同)决策的患者不太可能报告护理质量极好(优势比[OR],0.64;95%置信区间[CI],0.54-0.75;P<0.001)。患者偏好的决策角色并未改变这种影响(交互作用 P=0.29)。描述实际或偏好的医生控制(vs 共同)角色的患者不太可能对医生沟通给予最高评价(OR,0.55;95%CI,0.45-0.66;P<0.001,OR,0.67;95%CI,0.51-0.87;P=0.002)。偏好角色并未改变实际角色的效果(交互作用 P=0.76)。
肺癌或结直肠癌治疗的医生控制决策与较低的护理质量和医生沟通评分相关。这些影响独立于患者的偏好决策角色,强调了寻求让所有患者参与其治疗决策的重要性。